Cargando…

Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case–control study

BACKGROUND: Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical roles in transcription regulation, and their circulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Chun-Hsu, Chien, Shu-Chen, Chen, Chang-Jui, Shih, Chun-Ming, Hsieh, Ming-Hsiung, Huang, Chun-Yao, Bi, Wei-Fung, Chan, Chao-Shun, Kao, Yung-Ta, Hsiao, Cheng-Yi, Chiang, Shuo-Ju, Chiang, Kuang-Hsing, Huang, Jen-Hung, Liu, Yun-Ru, Luo, Ji-Dung, Huang, Hui-Yu, Wu, Chieh-Hsi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869494/ https://www.ncbi.nlm.nih.gov/pubmed/33557763 http://dx.doi.org/10.1186/s12872-021-01893-y

Ejemplares similares

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Effects of Tapered-Strut Design on Fatigue Life Enhancement of Peripheral Stents
por: Lin, Li-Han, et al.
Publicado: (2023)

Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation
por: Hsieh, I-Chang, et al.
Publicado: (2015)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Treatment of the Carotid In-stent Restenosis: A Systematic Review
por: Huang, Hao, et al.
Publicado: (2021)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study
por: Hsieh, Chi-Feng, et al.
Publicado: (2015)

Effectiveness and Adverse Events of Gabapentinoids as Analgesics for Patients with Burn Injuries: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
por: Chiang, Liang-Jui, et al.
Publicado: (2023)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
por: Lee, Yi-Yen, et al.
Publicado: (2018)

Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells
por: Chiang, Kuang-Hsing, et al.
Publicado: (2015)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
por: Liu, Yen-Wen, et al.
Publicado: (2021)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Combination treatment with asiaticoside and rapamycin: A new hope for in-stent restenosis
por: GUO, TIAN, et al.
Publicado: (2013)

Multiple Sequential Complications After Sirolimus-Eluting Stent Implantation: Very Late Stent Thrombosis, Stent Fracture, In-Stent Restenosis, and Peri-Stent Aneurysm
por: Seol, Sang-Hoon, et al.
Publicado: (2009)

Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology
por: Kao, Yung-Ta, et al.
Publicado: (2020)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo, Yinhua, et al.
Publicado: (2022)

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
por: Mao, Chun-Tai, et al.
Publicado: (2019)

The Impact of Matching Vaccine Strains and Post-SARS Public Health Efforts on Reducing Influenza-Associated Mortality among the Elderly
por: Chan, Ta-Chien, et al.
Publicado: (2010)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
por: Wang, Jing, et al.
Publicado: (2021)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

The usefulness of subtraction coronary computed tomography angiography for in-stent restenosis assessment of patients with CoCr stent using 320-row area detector CT
por: Li, Jian, et al.
Publicado: (2021)

‘Miracle stents’ - a future without restenosis
por: Hamid, Huda, et al.
Publicado: (2007)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vf3a2is6c9cpih2i7uqol4fu2n